Front > MARKET


Teva Photo: Sivan Faraj Teva opioid settlement talks reach impasse

While US State Attorneys were inclined to accept the deal, local government officials were opposed to the agreement.

Protalix  / Photo: Paul Orlive Protalix up 74% after positive Fabry disease trial results

The 12-month interim data from the first 16 of 22 adult patients enrolled demonstrate a mean improvement in kidney function.

Kare Schultz Photo: PR Teva jumps as US global opioid settlement moves nearer

"Reuters" reports that a federal judge has summoned Teva CEO Kare Schultz to discuss settling all 2,600 US suits alleging that the Israeli company fueled the opioid crisis.

Spotify Partner TV to launch Spotify for subscribers

Partner is offering Spotify Premium to subscribers for a free three month trial after which there will be a monthly fee of NIS 19.90.

Nati Saidoff Shikun & Binui reports delay on Texas toll road

Due to the delay the company will record a loss of $12-16 million in its third quarter financial results.

Together-Cannabliss Together begins growing cannabis commercially in Israel

The company has reported that it has switched to commercial cultivation at its farm in Ashkelon, after receiving IMC-GAP approval for the facility.

Zehavit Cohen  photo: Jonathan Bloom Tosca buys Israeli co Polymer Logistics

Based in Migdal Ha'Emek, Polymer Logistics manufactures reusable transport packaging and retail merchandizing systems.

Teva Photo: ASAP Creative Shutterstock Teva among cos offering $50b settlement of opioid claims

According to a report by Reuters, five pharmaceuticals and distribution companies involved in the opioids affair in the US are offering drugs worth $22 billion and services worth $28 billion.

Libra  / Photo illustration: Shutterstock, Facebook will be unable to control Libra

Libra’s distributed governance will encourage a new wave of innovation and competition in financial service - Facebook will only have one vote out of at least 100 - Libra's founder says.

Teva IBI: $15b in free drugs would only cost Teva $2b-4b

IBI Investment House pharma analyst Steven Tepper has calculated that the cost to Teva of a $15 billion opioid settlement would be dramatically less.

Mori Arkin  / Photo: PR Exalenz Bioscience seeks buyer

The company's trial of one product failed, and it downwardly revised its sales guidance.

Ron Lauder Photo: Tamar Matsafi Ron Lauder's sewage treatment co Fluence to raise A$30m

The private placement is taking place at a 12.9% discount on the ASX market price.

Itzhak Swary Allied Group buys 51% Autodeal stake for NIS 100m

Founders and co-CEOs Meir Ohayon and Tomer Dotan will continue managing the auto trade-in chain.

Shekel  / Photo: Shutterstock Shekel weakens further as inflation falls

Inflation in Israel over the past 12 months has fallen to just 0.3%, moving further away from the Bank of Israel's annual target range of 1%-3%.

Teva Photo: Sivan Faraj Teva offers $15b in drugs to settle opioid cases - report

The settlement would run over 10 years and the drugs would include Teva's Narcan for treating opioid addiction, sources told "Bloomberg."

Dov Tamarkin  / Photo: Ofir Farajun Cannabis co Intelicanna appoints Dov Tamarkin to board

Dr. Tamarkin founded Foamix Pharmaceuticals, which develops and commercializes pharmaceuticals in the dermatology sector.

Shekel  / Photo: Shutterstock Shekel continues to weaken ahead of Sep CPI

With hopes high for a Brexit settlement in the next few days between the UK and EU, sterling gained 1.485% against the shekel to NIS 4.442/£.

Israel Chemicals Israel Chemicals expands meat alternatives activities

ROVITARIS is a proprietary technology developed by Israel Chemicals, which supports the production of allergen free plant-based food.

Dr. Michael Hayden Photo: Tamar Matsafi Teva spin-off 89bio files for $70m Wall Street IPO

The Israeli biopharmaceutical company's lead candidate treats NASH, a severe form of nonalcoholic fatty liver disease.

ForeScout Photo: PR Forescout tumbles on profit warning

Forescout Technologies CEO Michael DeCesare: Q3 results were impacted by extended approval cycles which pushed several deals out of the third quarter.

Pnina Fishman photo: Eyal Izhar Capital Point's hostile bid for Can-Fite ends in compromise

Dr. Pnina Fishman will continue as Can-Fite BioPharma's CEO.

Medicine Photo: Reuters Israel's RDD Pharma merges with Innovate Biopharmaceuticals

The merged company will be listed on Nasdaq under the name 9 Meters Biopharma.

Aspire Global IPO Photo: PR Israeli co Aspire Global buys B2B iGaming co Pariplay

The acquisition of Pariplay allows Aspire Global to control yet another part of the iGaming value chain.

Jacob Luxenburg  photo: Tamar Matsafi Lapidoth Capital to buy Africa Israel

81% of the bondholders voted for Lapidoth Capital's bid after YH Dimri lowered its bid at the last minute.

Teva logistics center Photo: PR Amot buys Teva's logistics center for NIS 445m

Amot will lease back the logistics center to Teva subsidiary SLE, in a deal that will help improve Teva's current cash flow.

Sarona Market Big, Mega Or buy Sarona Market for NIS 160m

In recent months many businesses have left the Tel Aviv market after reporting weak sales.

Ilan Shiloah, Jonathan Benartzi and Nir Tarlovsky Akamai acquires Israeli co ChameleonX

Tel Aviv-based ChameleonX has developed self-protection technology for websites to prevent fraud and theft.

Shekel  / Photo: Shutterstock Shekel weakens on BoI rate cut talk

Bank of Israel Governor Prof. Amir Yaron observed that the Monetary Committee was not unanimous in keeping the rate unchanged and there were good reasons for cutting the rate below 0.25% already.

Jeremy Levin "From Teva's ashes new Israeli biotech can grow"

Former Teva CEO Jeremy Levin talks to "Globes" about Israel's biotech potential, the opioid disaster and why he shuns investing in medical cannabis.

Dror Sharon  / Photo: Eyal Izhar, Globes Magal awarded $8m East African deal

The company says that most of the order consists of follow-on orders to maintain systems for detecting penetration of an important seaport in the region.

Prisenso founders SKF buys Israeli AI co Presenso

The Haifa-based company develops and deploys artificial intelligence (AI)-based predictive maintenance software.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018